Advertisement

Archive

2016: 115/3 (Mar) pp. 465–684

Journal: Thrombosis and Haemostasis
ISSN: 0340-6245
Topic:

Theme Issue
Biomechanics in vascular biology and cardiovascular disease


26 articles
1.

Theme Issue Editorial for Theme Issue "Biomechanics in vascular biology and cardiovascular disease"

P. C. Evans (1), F. J. H. Gijsen (2), J. J. Wentzel (2), K. van der Heiden (2)

(1) Department of Cardiovascular Science, University of Sheffield, Sheffield, UK; (2) Department of Biomedical Engineering, Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands

Thromb Haemost 2016 115 3: 465-466

https://doi.org/10.1160/TH16-01-0075

[Summary] [Free PDF] [Export citation]
2.

Theme Issue Article to Theme Issue "Biomechanics in vascular biology and cardiovascular disease"

S. Lehoux (1), E. A. Jones (2)

(1) Lady Davis Institute, McGill University, Montreal, Quebec, Canada; (2) Centre for Molecular and Vascular Biology, KU Leuven, Leuven, Belgium

Thromb Haemost 2016 115 3: 467-473

https://doi.org/10.1160/TH15-10-0791

[Summary] [Free PDF] [Export citation]
3.

Theme Issue Article for Theme Issue "Biomechanics in vascular biology and cardiovascular disease"

Online Supplementary Material

N. Maimari (1, 2), R. M. Pedrigi (1), A. Russo (2), K. Broda (2), R. Krams (1)

(1) Department of Bioengineering, Imperial College London, UK; (2) Department of Computing, Imperial College London, UK

Thromb Haemost 2016 115 3: 474-483

https://doi.org/10.1160/TH15-09-0704

[Summary] [Free PDF] [Export citation]
4.

Theme Issue Article to Theme Issue "Biomechanics in vascular biology and cardiovascular disease"

U. Morbiducci (1), A. M. Kok (2), B. R. Kwak (3), P. H. Stone (4), D. A. Steinman (5), J. J. Wentzel (2)

(1) Department of Mechanical and Aerospace Engineering, Politecnico di Torino, Turin, Italy; (2) Department of Cardiology, Biomedical Engineering, Erasmus MC, Rotterdam, the Netherlands; (3) Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland; (4) Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA; (5) Department of Mechanical & Industrial Engineering, University of Toronto, Toronto, Ontario, Canada

Thromb Haemost 2016 115 3: 484-492

https://doi.org/10.1160/TH15-07-0597

[Summary] [Free PDF] [Export citation]
5.

Theme Issue Article for Theme Issue "Biomechanics in vascular biology and cardiovascular disease"

L. Speelman (1), Z. Teng (2), A. J. Nederveen (3), A. van der Lugt (4), J. H. Gillard (2)

(1) Department of Biomedical Engineering, Erasmus Medical Center, Rotterdam, The Netherlands; (2) Department of Radiology, University of Cambridge, School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK; (3) Department of Radiology, Academic Medical Center Amsterdam, University of Amsterdam, Amsterdam, The Netherlands; (4) Department of Radiology, Erasmus Medical Center, Rotterdam, The Netherlands

Thromb Haemost 2016 115 3: 493-500

https://doi.org/10.1160/TH15-09-0712

[Summary] [Free PDF] [Export citation]
6.

Theme Issue Article for Theme Issue "Biomechanics in vascular biology and cardiovascular disease"

K. van der Heiden (1), A. Hoogendoorn (1), M. J. Daemen (2), F. J. H. Gijsen (1)

(1) Department of Biomedical Engineering, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands; (2) Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

Thromb Haemost 2016 115 3: 501-508

https://doi.org/10.1160/TH15-07-0614

[Summary] [Free PDF] [Export citation]
7.

Theme Issue Article for Theme Issue "Biomechanics in vascular biology and cardiovascular disease"

S. J. White (1), A. C. Newby (1), T. W. Johnson (1, 2)

(1) University of Bristol, School of Clinical Sciences, Bristol, UK; (2) Bristol Heart Institute, Bristol, UK

Thromb Haemost 2016 115 3: 509-519

https://doi.org/10.1160/TH15-09-0765

[Summary] [Free PDF] [Export citation]
8.
The impact of statin therapy on plasma levels of von Willebrand factor antigen
Systematic review and meta-analysis of randomised placebo-controlled trials

A. Sahebkar (1, 2), C. Serban (3), S. Ursoniu (4), D. P. Mikhailidis (5), A. Undas (6), G. Y. H. Lip (7), V. Bittner (8), K. Ray (9), G. F. Watts (10), G. K. Hovingh (11), J. Rysz (12), J. J. P. Kastelein (11), M. Banach (12), Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group

(1) Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; (2) Metabolic Research Centre, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia, Australia; (3) Department of Functional Sciences, Discipline of Pathophysiology, “Victor Babes” University of Medicine and Pharmacy, Timisoara, Romania; (4) Department of Functional Sciences, Discipline of Public Health, “Victor Babes” University of Medicine and Pharmacy, Timisoara, Romania; (5) Department of Clinical Biochemistry, Royal Free Campus, University College London Medical School, University College London (UCL), London, UK; (6) Institute of Cardiology, Jagiellonian University Medical College, and John Paul II Hospital, Krakow, Poland; (7) University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK; (8) Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama, USA; (9) Department of Primary Care and Public Health, School of Public Health, Imperial College London, UK; (10) Lipid Disorders Clinic, Cardiovascular Medicine, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia, Perth, West Australia, Australia; (11) Department of Vascular Medicine, Academic Medical Center, Amsterdam, Netherlands; (12) Department of Hypertension, Chair of Nephrology and Hypertension, Medical University of Lodz, Lodz, Poland

Thromb Haemost 2016 115 3: 520-532

https://doi.org/10.1160/TH15-08-0620

[Summary] [Free PDF] [Export citation]
9.

S. J. Henderson (1, 2), J. Xia (3), H. Wu (3), A. R. Stafford (1, 4), B. A. Leslie (1, 4), J. C. Fredenburgh (1, 4), D. A. Weitz (3), J. I. Weitz (1, 2, 4, 5)

(1) Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, Ontario, Canada; (2) Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada; (3) School of Engineering and Applied Sciences, Harvard University, Cambridge, Massachusetts, USA; (4) Department of Medicine, McMaster University, Hamilton, Ontario, Canada; (5) Department of Medical Sciences, McMaster University, Hamilton, Ontario, Canada

Thromb Haemost 2016 115 3: 533-542

https://doi.org/10.1160/TH15-06-0462

[Summary] [PDF] [Pay per view] [Export citation]
10.

A. S. van Velzen (1), C. L. Eckhardt (1, 2), N. Streefkerk (1), M. Peters (1), D. P. Hart (3), K. Hamulyak (4), R. Klamroth (5), K. Meijer (6), M. Nijziel (7), P. Schinco (8), T. T. Yee (9), J. G. van der Bom (10), K. Fijnvandraat (1), for the INSIGHT study group

(1) Department of Pediatric Hematology, Emma Children’s Hospital, the Academic Medical Center, Amsterdam, the Netherlands; (2) Department of Vascular medicine, Academic Medical Center, Amsterdam, the Netherlands; (3) Royal London Hospital, Bart’s and The London School of Medicine and Dentistry, London, UK; (4) Maastricht University Medical Center, Maastricht, the Netherlands; (5) Vivantes Klinikum im Friedrichshain, Berlin, Germany; (6) University Medical Center Groningen, Groningen, the Netherlands; (7) Maxima Medical Center, Eindhoven/Veldhoven, the Netherlands; (8) San Giovanni Battista “Molinette” Hospital, Turin, Italy; (9) Royal Free Hospital, London, the UK; (10) Center for Clinical Transfusion Research, Sanquin Research and Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands

Thromb Haemost 2016 115 3: 543-550

https://doi.org/10.1160/TH15-03-0212

[Summary] [PDF] [Pay per view] [Export citation]
11.

Online Supplementary Material

V. Bhat (1, 2), A. von Drygalski (1, 2), A. J. Gale (1, 2), J. H. Griffin (1, 2), L. O. Mosnier (1)

(1) The Scripps Research Institute, Department of Molecular and Experimental Medicine, La Jolla, California, USA; (2) University California San Diego, Department of Medicine, Division of Hematology/Oncology, San Diego, California, USA

Thromb Haemost 2016 115 3: 551-561

https://doi.org/10.1160/TH15-07-0525

[Summary] [PDF] [Pay per view] [Export citation]
12.

K.-H. Liesenfeld (1), A. Clemens (2), J. Kreuzer (3), M. Brueckmann (3, 4), F. Schulze (3)

(1) Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riß, Germany; (2) Center for Thrombosis and Haemostasis, University Medical Centre, Mainz, Germany; (3) Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany; (4) Faculty of Medicine Mannheim of the University of Heidelberg, Mannheim, Germany

Thromb Haemost 2016 115 3: 562-569

https://doi.org/10.1160/TH15-07-0531

[Summary] [PDF] [Pay per view] [Export citation]
13.

M. Alhenc-Gelas (1), G. Plu-Bureau (2), M. H. Horellou (3), A. Rauch (4), P. Suchon (5), for the GEHT genetic thrombophilia group

(1) Hématologie biologique, AP-HP, Hôpital Européen G Pompidou, Hôpitaux Universitaires Paris Ouest, Paris, France; (2) Unité d’hémostase et Unité de Gynécologie endocrinienne, AP-HP, Hôpital Cochin, Hôpitaux universitaires Paris Centre, Faculté de Médecine Paris Descartes, Paris, France; (3) Laboratoire d’Hématologie, AP-HP Hôpital Cochin, Hôpitaux universitaires Paris Centre Faculté de Médecine Paris Descartes, Paris, France; (4) Pôle Biologie Pathologie Génétique, Institut d’Hématologie-Transfusion, CHRU, Lille, France; (5) Laboratoire d’hématologie, CHU La Timone, INSERM UMR S1062, Université Aix Marseille, Marseille, France

Thromb Haemost 2016 115 3: 570-579

https://doi.org/10.1160/TH15-05-0391

[Summary] [PDF] [Pay per view] [Export citation]
14.

S. Peraramelli (1), S. Thomassen (1), A. Heinzmann (1), T. M. Hackeng (1), R. Hartmann (2), F. Scheiflinger (2), M. Dockal (2), J. Rosing (1)

(1) Department of Biochemistry, Cardiovascular Research Institute Maastricht, University Maastricht, the Netherlands; (2) Baxalta Innovations GmbH, Vienna, Austria

Thromb Haemost 2016 115 3: 580-590

https://doi.org/10.1160/TH15-04-0354

[Summary] [PDF] [Pay per view] [Export citation]
15.
Open Access

Online Supplementary Material

C. Longstaff (1), J. Hogwood (1), E. Gray (1), E. Komorowicz (2), I. Varjú (2), Z. Varga (3), K. Kolev (2)

(1) Biotherapeutics, Haemostasis Section, National Institute for Biological Standards and Control, South Mimms, Potters Bar, UK; (2) Department of Medical Biochemistry, Semmelweis University, Budapest, Hungary; (3) Department of Biological Nanochemsitry, Institute of Materials and Environmental Chemistry, Research Centre for Natural Sciences, Hungarian Academy of Sciences, Budapest, Hungary

Thromb Haemost 2016 115 3: 591-599

https://doi.org/10.1160/TH15-03-0214

[Summary] [Free PDF] [Export citation]
16.

S.-M. Kim (1), Y.-W. Moon (2), S.-J. Lim (2), D.-W. Kim (2), Y.-S. Park (2)

(1) Department of Orthopaedic Surgery, Seoul Medical Center, Seoul, South Korea; (2) Department of Orthopaedic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea

Thromb Haemost 2016 115 3: 600-607

https://doi.org/10.1160/TH15-07-0527

[Summary] [PDF] [Pay per view] [Export citation]
17.

A. Brateanu (1), K. Patel (1), K. Chagin (2), P. Tunsupon (1), P. Yampikulsakul (1), G. V. Shah (1), S. Wangsiricharoen (1), L. Amah (1), J. Allen (1), A. Shapiro (1), N. Gupta (1), L. Morgan (1), R. Kumar (1), C. Nielsen (1), M. B. Rothberg (1)

(1) Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA; (2) Quantitative Health Sciences, Cleveland Clinic, Cleveland Clinic, Cleveland, Ohio, USA

Thromb Haemost 2016 115 3: 608-614

https://doi.org/10.1160/TH15-06-0503

[Summary] [PDF] [Pay per view] [Export citation]
18.

T. Gremmel (1), C. Ay (2), J. Riedl (2), C. W. Kopp (1), B. Eichelberger (3), R. Koppensteiner (1), S. Panzer (3)

(1) Division of Angiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria; (2) Clinical Division of Hematology and Hemostaseology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria; (3) Department of Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Vienna, Austria

Thromb Haemost 2016 115 3: 615-621

https://doi.org/10.1160/TH15-07-0598

[Summary] [PDF] [Pay per view] [Export citation]
19.

Online Supplementary Material

F. Franchi (1), F. Rollini (1), J. R. Cho (1), R. King (2), F. Phoenix (2), M. Bhatti (1), C. DeGroat (1), A. Tello-Montoliu (1), M. M. Zenni (1), L. A. Guzman (1), T. A. Bass (1), R. A. Ajjan (2), D. J. Angiolillo (1)

(1) University of Florida College of Medicine-Jacksonville, Jacksonville, Florida, USA; (2) Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK

Thromb Haemost 2016 115 3: 622-631

https://doi.org/10.1160/TH15-06-0467

[Summary] [PDF] [Pay per view] [Export citation]
20.

Online Supplementary Material

J.-J. Bei (1, 2), C. Liu (3), S. Peng (1), C.-H. Liu (1), W.-B. Zhao (1), X.-L. Qu (1), Q. Chen (1), Z. Zhou (3), Z.-P. Yu (3), K. Peter (4), H.-Y. Hu (1)

(1) Department of Cardiology, Southwest Hospital, Third Military Medical University, Chongqing, China; (2) Department of Cardiology, Guangxi Provincial Corps Hospital of CAPF, Nanning, Guangxi, China; (3) Department of Occupational Health, Faculty of Preventive Medicine, Third Military Medical University, Chongqing, China; (4) Atherothrombosis and Vascular Biology, Baker IDI Heart and Diabetes Institute, and Department of Medicine and Immunology, Monash University, Melbourne, Victoria, Australia

Thromb Haemost 2016 115 3: 632-645

https://doi.org/10.1160/TH15-04-0322

[Summary] [PDF] [Pay per view] [Export citation]
  1-20 21-26